We would love to hear your thoughts about our site and services, please take our survey here.
He gets a response from some on here and likes the attention. It's the only attention he has in his life.
He is a nothing. To me he is in a green box too, so he is less than a nothing.
LOL
Never heard that metric before! Would be much better off if they hd 50m market cap with 50,000 employees. That is desperate.
Can't stop laughing.
Yep, more meat on the bones as to how they're going to get to £100m by 2028.
I'm always impressed by MO, less so presentationally by Stephen but there's no doubt he knows his stuff too.
Miles provides positivity, awareness and good research / data. I for one am always glad when he's buying into stocks that I already hold.
Just be aware that he isn't going to tell you when he's selling, and sometimes not even after. He also has his fair share of duds.
We're also starting to see Shorts reducing across many brow beaten stocks now. This together with improved economics, lower interest rates (soon) and rapidly improving sentiment (yes, even in the London market, LOL) should see things improving for all of us.
The green shoots of spring are definitely appearing, but as you say Sieveco, ultimately it's results that matter. I have a lot of confidence n SL and BOOM as a whole to do their bit.
Dallo - No posts since 22 March.
Any thoughts on today's RNS and current SP as we close in on Results and Launch of tender Offer?
So many green boxes and I only have one person filtered.
I wonder if this guy when he's lying on his death bed will look back on his life and judge that he has used it well... after all he's wasted 5 years of it on here daily.
They will spend it, or at least a fair proportion of it. From the RNS
Whilst our existing HCT and Venn businesses are both delivering strong organic growth, we will seek to enhance this via our inorganic growth strategy, and we are actively assessing synergistic opportunities for small bolt-on acquisitions in the areas of drug development consulting, patient recruitment and clinical trial site services that will support our growth strategy whilst also diversifying the Group's revenue streams.
...or of course they could always do the right thing and up the tender offer to 275/300.
That would put the cat amongst the pigeons
What we need is the SP to head towards 250 and then all get the special divi due to there being no tender take up and also keep our shares, or simply sell out at that level.
It's all down to the price at the point the tender closes. I can't see how it can be much less than 250 and the process serve its purpose.
If the SP at tender close is 240+ then you might get to sell 90% of your holding (as not many will bother) but by the time you add fees and duties you won't make much if anything buying back. But if it is 245 then, as an RI, why bother with the tender? You could just take 245 and not have to wait for the money or have a partial take up.
Alternatively, if the SP is only 220 then you'll probably get to sell only 20% of your (tendered) holding anyway as everyone will think it is easy money, but...
I think with the significant reduction in liquidity once 14% has been removed from the market, that one way or another the SP will be 245+ and you won't get to buy back for any less than you sold for. The question you need to ask yourself is are you happy to walk away with 250, which is what they want you to do.
Questions, question...
It's difficult to beat guidance if you set it too high.
MOA - Under promise, over deliver.
Daphne moved on to Seaport - Major investors getting peeved with lack of shareholder value?
Good to see some action anyway.
Results to come very soon, closely followed by the launch of the tender offer. I've no idea what the strategy should be for that now with the SP languishing at 215.
Somethings leaked. Gone crazy
It's been boring a very long time, but you can't reason with someone who has psychologic issues. You just have to feel sorry for them.
It’s sets the tone for all future negotiations now.
ITX won’t be rolled over. I’m impressed by this, it means the management feel in control of their own business and aren’t in awe of their big clients.
Well played John.
It's time to shed the low margin contracts - There's no point being busy fools.
Don't be pushed around by the big boys, they pay the going rate or they go somewhere else.
...and despite that.... As per the trading update on 27 February 2024, the Company expects to announce final results for FY 2023 in line with current expectations, achieving another record year with unaudited revenues of $7.9 million, a substantial increase of 40.6% over FY 2022 of $5.6 million.
Full steam ahead.
Sorry, not AGM. The tender offer will be launched after publication of the Company's Full Year Results at some point during in April, so could be any time in the next few weeks.
There really is no point having a tender offer of £2.50 if the share price is north of £2.35 in my opinion.
I know it doesn't track consistently but the share price in the US is currently exactly $30 near to close on Monday.
That's the equivalent of approx £2.39 in the UK.
I can see it being very close to £2.50 by the AGM and the proposed tender sum being pointless. They need to raise it to £2.75/3.00 as I said in my last post or switch to a special dividend.
The reason that the MC of ITX isn't 10x its current level is simply because the UK market hasn't understood the science or the vast potential here.
In that way US investors are certainly more savvy.
Market Cap currently of £33m. Really. Add a 0 and it's still under valued.